These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 233228

  • 1. Demonstration of cells with Marek's disease tumor-associated surface antigen in chicks infected with herpesvirus of turkey, O1 strain.
    Kitamoto N, Ikuta K, Kato S, Wataki K.
    Biken J; 1979 Dec; 22(4):137-42. PubMed ID: 233228
    [Abstract] [Full Text] [Related]

  • 2. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.
    Schat KA, Calnek BW.
    J Natl Cancer Inst; 1978 Sep; 61(3):855-7. PubMed ID: 211242
    [Abstract] [Full Text] [Related]

  • 3. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I, Yuasa N, Horiuchi T, Tsubahara H.
    Natl Inst Anim Health Q (Tokyo); 1975 Sep; 15(1):1-7. PubMed ID: 804667
    [Abstract] [Full Text] [Related]

  • 4. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
    Witter RL, Sharma JM, Offenbecker L.
    Avian Dis; 1976 Sep; 20(4):676-92. PubMed ID: 186008
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cell-mediated cytotoxicity of lymphocytes from chickens inoculated with herpesvirus of turkey against a Marek's disease lymphoma cell line (MSB-1).
    Kitamoto N, Ikuta K, Kato S, Yamaguchi S.
    Biken J; 1979 Mar; 22(1):11-20. PubMed ID: 317001
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW, Gelb J, Schreurs CS, Lütticken D, Rosenberger JK, Sondermeijer PJ.
    Avian Dis; 1992 Mar; 36(4):858-70. PubMed ID: 1485872
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.
    Rispens BH, van Vloten H, Mastenbroek N, Maas HJ, Schat KA.
    Avian Dis; 1972 Apr; 16(1):108-25. PubMed ID: 4337307
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of herpesvirus of turkeys vaccine against challenge with Marek's disease tumor cells.
    Donahoe JP, Kleven SH.
    Avian Dis; 1977 Apr; 21(3):436-9. PubMed ID: 907584
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.